Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable ...

The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory submissions.

Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug ...

All patients said insulin pump therapy helped their diabetes management related to exercise. Older patients with type 1 diabetes (T1D) appear to benefit from insulin pumps and continuous glucose ...

A large registry study in young people with type 1 diabetes found that hybrid closed-loop systems were linked to slightly better HbA1c and more time in the target glucose range than open-loop pump ...

Just a few weeks into the full-scale rollout of its Omnipod 5 insulin pump, Insulet has gotten the green light to expand the device’s reach even further. When the FDA originally cleared the automated, ...

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...

Please provide your email address to receive an email when new articles are posted on . Insulin pump and continuous glucose monitor use were lower among Black young adults with type 1 diabetes in the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A follow-on therapy to insulin aspart was shown to be ...